Cargando…

Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial

BACKGROUND: To determine the cost-effectiveness of strategies of preferred antibiotic treatment with beta-lactam/macrolide combination or fluoroquinolone monotherapy compared to beta-lactam monotherapy. METHODS: Costs and effects were estimated using data from a cluster-randomized cross-over trial o...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Werkhoven, Cornelis H., Postma, Douwe F., Mangen, Marie-Josee J., Oosterheert, Jan Jelrik, Bonten, Marc J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223446/ https://www.ncbi.nlm.nih.gov/pubmed/28068956 http://dx.doi.org/10.1186/s12879-016-2179-6

Ejemplares similares

Predictors of Bacteraemia in Patients with Suspected Community-Acquired Pneumonia
por: van Werkhoven, Cornelis H., et al.
Publicado: (2015)

Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial
por: Postma, Douwe F., et al.
Publicado: (2019)

Community-Acquired Pneumonia—Back to Basics
por: Bonten, Marc J.M., et al.
Publicado: (2008)

Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
por: Vissink, Conrad E., et al.
Publicado: (2016)

Rationale and design of the costs, health status and outcomes in community-acquired pneumonia (CHO-CAP) study in elderly persons hospitalized with CAP
por: Mangen, Marie-Josée J, et al.
Publicado: (2013)

Confounding by indication of the safety of de-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort
por: van Heijl, Inger, et al.
Publicado: (2019)

Erratum to: Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
por: Vissink, Conrad E., et al.
Publicado: (2016)

The impact of community-acquired pneumonia on the health-related quality-of-life in elderly
por: Mangen, Marie-Josée J., et al.
Publicado: (2017)

803 Direct Costs and Duration of Hospitalization of Patients Hospitalized with Community Acquired Pneumonia: a Nationwide Retrospective Claims Database Analysis
por: Rozenbaum, Mark, et al.
Publicado: (2014)

Quality of life in community-dwelling Dutch elderly measured by EQ-5D-3L
por: Mangen, Marie-Josée J., et al.
Publicado: (2017)

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
por: Mangen, Marie-Josée J., et al.
Publicado: (2015)

Time for first antibiotic dose is not predictive for the early clinical failure of moderate–severe community-acquired pneumonia
por: Bruns, A. H. W., et al.
Publicado: (2009)

Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination
por: Bruijning-Verhagen, Patricia, et al.
Publicado: (2013)

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
por: Rozenbaum, Mark H, et al.
Publicado: (2011)

The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial
por: Huijts, S.M., et al.
Publicado: (2018)

Can we predict septic shock in patients with hospital-acquired pneumonia?
por: de Lange, Dylan W, et al.
Publicado: (2005)

Pneumonia Recovery; Discrepancies in Perspectives of the Radiologist, Physician and Patient
por: Bruns, Anke H. W., et al.
Publicado: (2009)

Cost-Effectiveness Of Culture-Based Versus Empirical Antibiotic Treatment For Hospitalized Adults With Community-Acquired Pneumonia In Indonesia: A Real-World Patient-Database Study
por: Purba, Abdul Khairul Rizki, et al.
Publicado: (2019)

Antibiotic rotation strategies to reduce antimicrobial resistance in Gram-negative bacteria in European intensive care units: study protocol for a cluster-randomized crossover controlled trial
por: van Duijn, Pleun J, et al.
Publicado: (2014)

Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study
por: Marbus, Sierk D., et al.
Publicado: (2020)

1091 Serotype Distribution of S. pneumoniae Community Acquired Pneumonia (CAP) in Adults in the Netherlands in the CAPiTA (Community-Acquired Pneumonia Immunization Trial In Adults) Study Period
por: Hollingsworth, Rosalind, et al.
Publicado: (2014)

Combination antibiotic therapy for community-acquired pneumonia
por: Caballero, Jesus, et al.
Publicado: (2011)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
por: Lopes, Mariana, et al.
Publicado: (2021)

Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis
por: ten Doesschate, Thijs, et al.
Publicado: (2019)

Rabies vaccination strategies in the Netherlands in 2018: a cost evaluation
por: Suijkerbuijk, Anita WM, et al.
Publicado: (2020)

Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial
por: Koekenbier, Eva L., et al.
Publicado: (2023)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
por: Jung, Yun Jung, et al.
Publicado: (2022)

595 Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
por: Bonten, Marc, et al.
Publicado: (2014)

EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece
por: Yfantopoulos, N, et al.
Publicado: (2022)

Inappropriate Use of Antimicrobials for Lower Respiratory Tract Infections in Elderly Patients: Patient- and Community-Related Implications and Possible Interventions
por: van Heijl, Inger, et al.
Publicado: (2018)

No increased risk of mature B-cell non-Hodgkin lymphoma after Q fever detected: results from a 16-year ecological analysis of the Dutch population incorporating the 2007–2010 Q fever outbreak
por: Weehuizen, Jesper M, et al.
Publicado: (2022)

The prognostic value of red blood cell distribution width in patients with suspected infection in the emergency department
por: Uffen, Jan Willem, et al.
Publicado: (2019)

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia
por: Lee, Mi Suk, et al.
Publicado: (2018)

Clinical response to antibiotic therapy for community-acquired pneumonia
por: Juvén, Taina, et al.
Publicado: (2004)

Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy
por: Liang, Junyu, et al.
Publicado: (2020)

Use of intravenous antibiotics for the treatment of community-acquired pneumonia in the emergency department
por: Carrie, Anita G, et al.
Publicado: (2005)

1991. Implementation of Rapid Turnaround PCR Bacterial/Viral Panel Testing in Community-acquired Pneumonia Decreases LOS, Antibiotic Cost, Antibiotic Charges, and Antibiotic Use
por: Shadowen, Rebecca D, et al.
Publicado: (2019)

The dilemma of improving rational antibiotic use in pediatric community-acquired pneumonia
por: Nguyen, Phuong T. K., et al.
Publicado: (2023)

Cost and Effects of Different Admission Screening Strategies to Control the Spread of Methicillin-resistant Staphylococcus aureus
por: Gurieva, Tanya, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_plak7591a3boobqm9qq7tl837u